G De Angelis1, N T Mutters2, L Minkley3, F Holderried3, E Tacconelli4. 1. Department of Microbiology, Catholic University, largo A. Gemelli 8, 00164, Rome, Italy. 2. Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Im Neuenheimer Feld 324, 69120, Heidelberg, Germany. 3. Division of Infectious Diseases, Department of Internal Medicine I, Raum 925, Ebene 3 Gebäude Nord, Tübingen University Hospital, Otfried-Müller-Straße 12, 72076, Tübingen, Germany. 4. Division of Infectious Diseases, Department of Internal Medicine I, Raum 925, Ebene 3 Gebäude Nord, Tübingen University Hospital, Otfried-Müller-Straße 12, 72076, Tübingen, Germany. Evelina.Tacconelli@med.uni-tuebingen.de.
Abstract
INTRODUCTION: Recent age-projection showed that the number of elderly is expected to rise significantly over the next decades worldwide. Accordingly, the prevalence of chronic and degenerative diseases will increase, among them osteoarthritis, resulting in more and older patients undergoing total joint arthroplasty and thereby also being at risk for associated complications. Among those, prosthetic joint infections are feared as threatening complication with a mortality approaching 8 % and causing long-term antibiotic therapy, immobilization and often account for operative revision. MATERIALS AND METHODS: This review summarizes epidemiological, microbiological, and therapeutic aspects of prosthetic joint infection in the elderly population. CONCLUSION: Considering the increase in the number of PJIs in the forthcoming years in most countries, a common action to reduce the associated morbidity and mortality is strongly encouraged in Europe.
INTRODUCTION: Recent age-projection showed that the number of elderly is expected to rise significantly over the next decades worldwide. Accordingly, the prevalence of chronic and degenerative diseases will increase, among them osteoarthritis, resulting in more and older patients undergoing total joint arthroplasty and thereby also being at risk for associated complications. Among those, prosthetic joint infections are feared as threatening complication with a mortality approaching 8 % and causing long-term antibiotic therapy, immobilization and often account for operative revision. MATERIALS AND METHODS: This review summarizes epidemiological, microbiological, and therapeutic aspects of prosthetic joint infection in the elderly population. CONCLUSION: Considering the increase in the number of PJIs in the forthcoming years in most countries, a common action to reduce the associated morbidity and mortality is strongly encouraged in Europe.
Authors: Matteo Bassetti; Francesco Vitale; Giovanna Melica; Elda Righi; Antonio Di Biagio; Luigi Molfetta; Francesco Pipino; Mario Cruciani; Dante Bassetti Journal: J Antimicrob Chemother Date: 2005-02-10 Impact factor: 5.790
Authors: Elie F Berbari; Camelia Marculescu; Irene Sia; Brian D Lahr; Arlen D Hanssen; James M Steckelberg; Rachel Gullerud; Douglas R Osmon Journal: Clin Infect Dis Date: 2007-09-26 Impact factor: 9.079
Authors: Sarah B Lieber; Mary Louise Fowler; Clara Zhu; Andrew Moore; Robert H Shmerling; Ziv Paz Journal: Infection Date: 2017-05-29 Impact factor: 3.553
Authors: T Latha; Anil K Bhat; H Manjunatha Hande; Chiranjay Mukhopadhyay; Elsa Sanatombi Devi; Baby S Nayak; Anice George Journal: Indian J Orthop Date: 2022-08-20 Impact factor: 1.033
Authors: P M Tsimbouri; L Fisher; N Holloway; T Sjostrom; A H Nobbs; R M D Meek; B Su; M J Dalby Journal: Sci Rep Date: 2016-11-18 Impact factor: 4.379
Authors: Jiri Gallo; Ales Panacek; Robert Prucek; Eva Kriegova; Sarka Hradilova; Martin Hobza; Martin Holinka Journal: Materials (Basel) Date: 2016-05-05 Impact factor: 3.623